MedPath

河北天成药业股份有限公司

Ownership
-
Established
1998-09-28
Employees
-
Market Cap
-
Website
http://www.hbtcyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

234

NMPA:234

Drug Approvals

Sodium Bicarbonate Ringer's Injection

Product Name
碳酸氢钠林格注射液
Approval Number
国药准字H20253716
Approval Date
Mar 25, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258043
Approval Date
Mar 25, 2025
NMPA

Calcium Chloride Injection

Product Name
氯化钙注射液
Approval Number
国药准字H20258034
Approval Date
Mar 21, 2025
NMPA

Calcium Chloride Injection

Product Name
氯化钙注射液
Approval Number
国药准字H20258035
Approval Date
Mar 21, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20258004
Approval Date
Jan 9, 2025
NMPA

Moxifloxacin Hydrochloride Tablets

Product Name
盐酸莫西沙星片
Approval Number
国药准字H20253104
Approval Date
Jan 8, 2025
NMPA

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Product Name
盐酸莫西沙星氯化钠注射液
Approval Number
国药准字H20244974
Approval Date
Sep 26, 2024
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20243586
Approval Date
Jul 23, 2024
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20243585
Approval Date
Jul 23, 2024
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H20247172
Approval Date
Jul 22, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 24
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.